Wounds that will not heal: Pervasive cellular reprogramming in cancer

American Journal of Pathology

Volumn 182, Issue 4, 2013, Pages 1055-1064

  Byun, Jung S ^a   Gardner, Kevin ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGENASE 3; GELATINASE B; MATRIX METALLOPROTEINASE 14; STROMELYSIN;

BREAST CANCER; ENDOTHELIUM CELL; EPIGENETICS; EXTRACELLULAR SPACE; HUMAN; MACROPHAGE; MOLECULAR INTERACTION; MYOFIBROBLAST; NEOPLASM; NONHUMAN; NUCLEAR REPROGRAMMING; PRIORITY JOURNAL; REVIEW; STROMA; TUMOR GROWTH; TUMOR MICROENVIRONMENT; WOUND HEALING;

ANIMALS; EPIGENESIS, GENETIC; HUMANS; MYOFIBROBLASTS; NEOPLASMS; NUCLEAR REPROGRAMMING; TUMOR MICROENVIRONMENT; WOUND HEALING;

EID: 84875123308     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2013.01.009     Document Type: Review

References (119)

1. R. Virchow Die Cellularpathologie in Ihrer Begründung auf Physiologische und Pathologische Gewebelehre 1858 A. Hirschwald Berlin pp xvi, 440
2. N.M. Alter Mechanical irritation as etiologic factor of cancer: clinical observation Am J Pathol 1 1925 511 518.3
3. H.F. Dvorak Tumors: wounds that do not heal: similarities between tumor stroma generation and wound healing N Engl J Med 315 1986 1650 1659
4. A. Haddow Molecular repair, wound healing, and carcinogenesis: tumor production a possible overhealing? Adv Cancer Res 16 1972 181 234
5. H. Akaiwa A quantitative study of wound healing in the rat, I: cell movements and cell layers during wound healing J Med Res 40 1919 311 351
6. L. Loeb A comparative study of the mechanism of wound healing J Med Res 41 1920 247 281
7. H.F. Dvorak Rous-Whipple Award Lecture: how tumors make bad blood vessels and stroma Am J Pathol 162 2003 1747 1757
8. D.G. McKay Participation of components of the blood coagulation system in the inflammatory response Am J Pathol 67 1972 181 210
9. V. Kumar, A.K. Abbas, J.C. Aster, and S.L. Robbins Robbins Basic Pathology 2013 Elsevier/Saunders Philadelphia pp 83
10. R.A. Clark, J.M. Lanigan, P. DellaPelle, E. Manseau, H.F. Dvorak, and R.B. Colvin Fibronectin and fibrin provide a provisional matrix for epidermal cell migration during wound reepithelialization J Invest Dermatol 79 1982 264 269
11. H.F. Dvorak, D.R. Senger, and A.M. Dvorak Fibrin as a component of the tumor stroma: origins and biological significance Cancer Metastasis Rev 2 1983 41 73
12. M.M. Markiewski, and J.D. Lambris The role of complement in inflammatory diseases from behind the scenes into the spotlight Am J Pathol 171 2007 715 727
13. M. Schäfer, and S. Werner Cancer as an overhealing wound: an old hypothesis revisited Nat Rev Mol Cell Biol 9 2008 628 638
14. J. Folkman Tumor angiogenesis: therapeutic implications N Engl J Med 285 1971 1182 1186
15. D.R. Senger, S.J. Galli, A.M. Dvorak, C.A. Perruzzi, V.S. Harvey, and H.F. Dvorak Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid Science 219 1983 983 985
16. A. Mantovani, and M. Locati Orchestration of macrophage polarization Blood 114 2009 3135 3136
17. S. Gordon, and F.O. Martinez Alternative activation of macrophages: mechanism and functions Immunity 32 2010 593 604
18. G. Solinas, G. Germano, A. Mantovani, and P. Allavena Tumor-associated macrophages (TAM) as major players of the cancer-related inflammation J Leukoc Biol 86 2009 1065 1073
19. A. Sica, P. Larghi, A. Mancino, L. Rubino, C. Porta, M.G. Totaro, M. Rimoldi, S.K. Biswas, P. Allavena, and A. Mantovani Macrophage polarization in tumour progression Semin Cancer Biol 18 2008 349 355
20. L.S. Ojalvo, W. King, D. Cox, and J.W. Pollard High-density gene expression analysis of tumor-associated macrophages from mouse mammary tumors Am J Pathol 174 2009 1048 1064
21. R.D. Stout, S.K. Watkins, and J. Suttles Functional plasticity of macrophages: in situ reprogramming of tumor-associated macrophages J Leukoc Biol 86 2009 1105 1109
22. A. Mantovani, G. Germano, F. Marchesi, M. Locatelli, and S.K. Biswas Cancer-promoting tumor-associated macrophages: new vistas and open questions Eur J Immunol 41 2011 2522 2525
23. D.M. Mosser, and J.P. Edwards Exploring the full spectrum of macrophage activation Nat Rev Immunol 8 2008 958 969
24. L. Bingle, N.J. Brown, and C.E. Lewis The role of tumour-associated macrophages in tumour progression: implications for new anticancer therapies J Pathol 196 2002 254 265
25. A. Schmieder, J. Michel, K. Schonhaar, S. Goerdt, and K. Schledzewski Differentiation and gene expression profile of tumor-associated macrophages Semin Cancer Biol 22 2012 289 297
26. R.A. Mukhtar, O. Nseyo, M.J. Campbell, and L.J. Esserman Tumor-associated macrophages in breast cancer as potential biomarkers for new treatments and diagnostics Expert Rev Mol Diagn 11 2011 91 100
27. D.N. Martin, B.J. Boersma, M. Yi, M. Reimers, T.M. Howe, H.G. Yfantis, Y.C. Tsai, E.H. Williams, D.H. Lee, R.M. Stephens, A.M. Weissman, and S. Ambs Differences in the tumor microenvironment between African-American and European-American breast cancer patients PLoS One 4 2009 e4531
28. R.A. Mukhtar, A.P. Moore, O. Nseyo, F.L. Baehner, A. Au, D.H. Moore, P. Twomey, M.J. Campbell, and L.J. Esserman Elevated PCNA+ tumor-associated macrophages in breast cancer are associated with early recurrence and non-Caucasian ethnicity Breast Cancer Res Treat 130 2011 635 644
29. K.L. Talks, H. Turley, K.C. Gatter, P.H. Maxwell, C.W. Pugh, P.J. Ratcliffe, and A.L. Harris The expression and distribution of the hypoxia-inducible factors HIF-1alpha and HIF-2alpha in normal human tissues, cancers, and tumor-associated macrophages Am J Pathol 157 2000 411 421
30. R.J. Eddy, J.A. Petro, and J.J. Tomasek Evidence for the nonmuscle nature of the "myofibroblast" of granulation tissue and hypertropic scar: an immunofluorescence study Am J Pathol 130 1988 252 260
31. B. Hinz, S.H. Phan, V.J. Thannickal, A. Galli, M.L. Bochaton-Piallat, and G. Gabbiani The myofibroblast: one function, multiple origins Am J Pathol 170 2007 1807 1816
32. B. Hinz, S.H. Phan, V.J. Thannickal, M. Prunotto, A. Desmouliere, J. Varga, O. De Wever, M. Mareel, and G. Gabbiani Recent developments in myofibroblast biology: paradigms for connective tissue remodeling Am J Pathol 180 2012 1340 1355
33. R. Kalluri, and M. Zeisberg Fibroblasts in cancer Nat Rev Cancer 6 2006 392 401
34. M. Otranto, V. Sarrazy, F. Bonté, B. Hinz, G. Gabbiani, and A. Desmoulière The role of the myofibroblast in tumor stroma remodeling Cell Adh Migr 6 2012 203 219
35. H.Y. Chang, J.T. Chi, S. Dudoit, C. Bondre, M. van de Rijn, D. Botstein, and P.O. Brown Diversity, topographic differentiation, and positional memory in human fibroblasts Proc Natl Acad Sci U S A 99 2002 12877 12882
36. J.J. Tomasek, G. Gabbiani, B. Hinz, C. Chaponnier, and R.A. Brown Myofibroblasts and mechano-regulation of connective tissue remodelling Nat Rev Mol Cell Biol 3 2002 349 363
37. F. Grinnell, M. Zhu, M.A. Carlson, and J.M. Abrams Release of mechanical tension triggers apoptosis of human fibroblasts in a model of regressing granulation tissue Exp Cell Res 248 1999 608 619
38. M. Labelle, S. Begum, and R.O. Hynes Direct signaling between platelets and cancer cells induces an epithelial-mesenchymal-like transition and promotes metastasis Cancer Cell 20 2011 576 590
39. J.A. Cho, H. Park, E.H. Lim, and K.W. Lee Exosomes from breast cancer cells can convert adipose tissue-derived mesenchymal stem cells into myofibroblast-like cells Int J Oncol 40 2012 130 138
40. J. Webber, R. Steadman, M.D. Mason, Z. Tabi, and A. Clayton Cancer exosomes trigger fibroblast to myofibroblast differentiation Cancer Res 70 2010 9621 9630
41. D. Di Vizio, M. Morello, A.C. Dudley, P.W. Schow, R.M. Adam, S. Morley, D. Mulholland, M. Rotinen, M.H. Hager, L. Insabato, M.A. Moses, F. Demichelis, M.P. Lisanti, H. Wu, M. Klagsbrun, N.A. Bhowmick, M.A. Rubin, C. D'Souza-Schorey, and M.R. Freeman Large oncosomes in human prostate cancer tissues and in the circulation of mice with metastatic disease Am J Pathol 181 2012 1573 1584
42. M. Zeisberg, G. Bonner, Y. Maeshima, P. Colorado, G.A. Muller, F. Strutz, and R. Kalluri Renal fibrosis: collagen composition and assembly regulates epithelial-mesenchymal transdifferentiation Am J Pathol 159 2001 1313 1321
43. A. Kizu, D. Medici, and R. Kalluri Endothelial-mesenchymal transition as a novel mechanism for generating myofibroblasts during diabetic nephropathy Am J Pathol 175 2009 1371 1373
44. L. Bianchetti, M. Barczyk, J. Cardoso, M. Schmidt, A. Bellini, and S. Mattoli Extracellular matrix remodelling properties of human fibrocytes J Cell Mol Med 16 2012 483 495
45. R. Bucala, L.A. Spiegel, J. Chesney, M. Hogan, and A. Cerami Circulating fibrocytes define a new leukocyte subpopulation that mediates tissue repair Mol Med 1 1994 71 81
46. P.J. Mishra, J.W. Glod, and D. Banerjee Mesenchymal stem cells: flip side of the coin Cancer Res 69 2009 1255 1258
47. B.D. Humphreys, S.L. Lin, A. Kobayashi, T.E. Hudson, B.T. Nowlin, J.V. Bonventre, M.T. Valerius, A.P. McMahon, and J.S. Duffield Fate tracing reveals the pericyte and not epithelial origin of myofibroblasts in kidney fibrosis Am J Pathol 176 2010 85 97
48. C. Goritz, D.O. Dias, N. Tomilin, M. Barbacid, O. Shupliakov, and J. Frisen A pericyte origin of spinal cord scar tissue Science 333 2011 238 242
49. M.M. Verbeek, I. Otte-Holler, P. Wesseling, D.J. Ruiter, and R.M. de Waal Induction of alpha-smooth muscle actin expression in cultured human brain pericytes by transforming growth factor-beta 1 Am J Pathol 144 1994 372 382
50. A.M. Gressner Transdifferentiation of hepatic stellate cells (Ito cells) to myofibroblasts: a key event in hepatic fibrogenesis Kidney Int Suppl 54 1996 S39 S45
51. L. Qin, and Y.P. Han Epigenetic repression of matrix metalloproteinases in myofibroblastic hepatic stellate cells through histone deacetylases 4: implication in tissue fibrosis Am J Pathol 177 2010 1915 1928
52. M. Coen, G. Gabbiani, and M.L. Bochaton-Piallat Myofibroblast-mediated adventitial remodeling: an underestimated player in arterial pathology Arterioscler Thromb Vasc Biol 31 2011 2391 2396
53. E.M. Zeisberg, S.E. Potenta, H. Sugimoto, M. Zeisberg, and R. Kalluri Fibroblasts in kidney fibrosis emerge via endothelial-to-mesenchymal transition J Am Soc Nephrol 19 2008 2282 2287
54. S. Piera-Velazquez, Z. Li, and S.A. Jimenez Role of endothelial- mesenchymal transition (EndoMT) in the pathogenesis of fibrotic disorders Am J Pathol 179 2011 1074 1080
55. P. Lu, K. Takai, V.M. Weaver, and Z. Werb Extracellular matrix degradation and remodeling in development and disease Cold Spring Harbor Perspect Biol 3 2011 pii:a005058
56. S.L. Nishimura Integrin-mediated transforming growth factor-beta activation, a potential therapeutic target in fibrogenic disorders Am J Pathol 175 2009 1362 1370
57. D. Sheppard Integrin-mediated activation of latent transforming growth factor beta Cancer Metastasis Rev 24 2005 395 402
58. J.J. Tomasek, J. McRae, G.K. Owens, and C.J. Haaksma Regulation of alpha-smooth muscle actin expression in granulation tissue myofibroblasts is dependent on the intronic CArG element and the transforming growth factor-beta1 control element Am J Pathol 166 2005 1343 1351
59. R.M. Simpson, S. Meran, D. Thomas, P. Stephens, T. Bowen, R. Steadman, and A. Phillips Age-related changes in pericellular hyaluronan organization leads to impaired dermal fibroblast to myofibroblast differentiation Am J Pathol 175 2009 1915 1928
60. J. Webber, R.H. Jenkins, S. Meran, A. Phillips, and R. Steadman Modulation of TGFbeta1-dependent myofibroblast differentiation by hyaluronan Am J Pathol 175 2009 148 160
61. S. Meran, D.D. Luo, R. Simpson, J. Martin, A. Wells, R. Steadman, and A.O. Phillips Hyaluronan facilitates transforming growth factor-beta1-dependent proliferation via CD44 and epidermal growth factor receptor interaction J Biol Chem 286 2011 17618 17630
62. F. Sotgia, F. Del Galdo, M.C. Casimiro, G. Bonuccelli, I. Mercier, D. Whitaker-Menezes, K.M. Daumer, J. Zhou, C. Wang, S. Katiyar, H. Xu, E. Bosco, A.A. Quong, B. Aronow, A.K. Witkiewicz, C. Minetti, P.G. Frank, S.A. Jimenez, E.S. Knudsen, R.G. Pestell, and M.P. Lisanti Caveolin-1-/- null mammary stromal fibroblasts share characteristics with human breast cancer-associated fibroblasts Am J Pathol 174 2009 746 761
63. U.E. Martinez-Outschoorn, S. Pavlides, D. Whitaker-Menezes, K.M. Daumer, J.N. Milliman, B. Chiavarina, G. Migneco, A.K. Witkiewicz, M.P. Martinez-Cantarin, N. Flomenberg, A. Howell, R.G. Pestell, M.P. Lisanti, and F. Sotgia Tumor cells induce the cancer associated fibroblast phenotype via caveolin-1 degradation: implications for breast cancer and DCIS therapy with autophagy inhibitors Cell Cycle 9 2010 2423 2433
64. T. Li, F. Sotgia, M.A. Vuolo, M. Li, W.C. Yang, R.G. Pestell, J.A. Sparano, and M.P. Lisanti Caveolin-1 mutations in human breast cancer: functional association with estrogen receptor alpha-positive status Am J Pathol 168 2006 1998 2013
65. P. Carmeliet, and R.K. Jain Molecular mechanisms and clinical applications of angiogenesis Nature 473 2011 298 307
66. J.I. Virag, and C.E. Murry Myofibroblast and endothelial cell proliferation during murine myocardial infarct repair Am J Pathol 163 2003 2433 2440
67. E.M. Zeisberg, S. Potenta, L. Xie, M. Zeisberg, and R. Kalluri Discovery of endothelial to mesenchymal transition as a source for carcinoma-associated fibroblasts Cancer Res 67 2007 10123 10128
68. D. Ribatti, B. Nico, and E. Crivellato The role of pericytes in angiogenesis Int J Dev Biol 55 2011 261 268
69. A. Raza, M.J. Franklin, and A.Z. Dudek Pericytes and vessel maturation during tumor angiogenesis and metastasis Am J Hematol 85 2010 593 598
70. S.L. Lin, T. Kisseleva, D.A. Brenner, and J.S. Duffield Pericytes and perivascular fibroblasts are the primary source of collagen-producing cells in obstructive fibrosis of the kidney Am J Pathol 173 2008 1617 1627
71. S. Morikawa, P. Baluk, T. Kaidoh, A. Haskell, R.K. Jain, and D.M. McDonald Abnormalities in pericytes on blood vessels and endothelial sprouts in tumors Am J Pathol 160 2002 985 1000
72. E.V. Sugarbaker Some characteristics of metastasis in man Am J Pathol 97 1979 623 632
73. R.J. Weil, D.C. Palmieri, J.L. Bronder, A.M. Stark, and P.S. Steeg Breast cancer metastasis to the central nervous system Am J Pathol 167 2005 913 920
74. S. Valastyan, and R.A. Weinberg Tumor metastasis: molecular insights and evolving paradigms Cell 147 2011 275 292
75. N.P. Gunasinghe, A. Wells, E.W. Thompson, and H.J. Hugo Mesenchymal-epithelial transition (MET) as a mechanism for metastatic colonisation in breast cancer Cancer Metastasis Rev 31 2012 469 478
76. M.A. Nieto, and A. Cano The epithelial-mesenchymal transition under control: global programs to regulate epithelial plasticity Semin Cancer Biol 22 2012 361 368
77. R. Kalluri, and R.A. Weinberg The basics of epithelial-mesenchymal transition J Clin Invest 119 2009 1420 1428
78. K. Polyak, and R.A. Weinberg Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits Nat Rev Cancer 9 2009 265 273
79. M.W. Klymkowsky, and P. Savagner Epithelial-mesenchymal transition: a cancer researcher's conceptual friend and foe Am J Pathol 174 2009 1588 1593
80. C. Scheel, and R.A. Weinberg Cancer stem cells and epithelial-mesenchymal transition: concepts and molecular links Semin Cancer Biol 22 2012 396 403
81. N.S. Nagathihalli, P.P. Massion, A.L. Gonzalez, P. Lu, and P.K. Datta Smoking induces epithelial-to-mesenchymal transition in non-small cell lung cancer through HDAC-mediated downregulation of E-cadherin Mol Cancer Ther 11 2012 2362 2372
82. D.L. Bolender, and R.R. Markwald Epithelial-mesenchymal transformation in chick atrioventricular cushion morphogenesis Scan Electron Microsc 3 1979 313 321
83. J.D. Hood, and D.A. Cheresh Role of integrins in cell invasion and migration Nat Rev Cancer 2 2002 91 100
84. G.K. Koukoulis, I. Virtanen, M. Korhonen, L. Laitinen, V. Quaranta, and V.E. Gould Immunohistochemical localization of integrins in the normal, hyperplastic, and neoplastic breast: correlations with their functions as receptors and cell adhesion molecules Am J Pathol 139 1991 787 799
85. M.M. Zutter, G. Mazoujian, and S.A. Santoro Decreased expression of integrin adhesive protein receptors in adenocarcinoma of the breast Am J Pathol 137 1990 863 870
86. A. Oloumi, T. McPhee, and S. Dedhar Regulation of E-cadherin expression and beta-catenin/Tcf transcriptional activity by the integrin-linked kinase Biochim Biophys Acta 1691 2004 1 15
87. M. Luo, and J.L. Guan Focal adhesion kinase: a prominent determinant in breast cancer initiation, progression and metastasis Cancer Lett 289 2010 127 139
88. G. van der Pluijm, B. Sijmons, H. Vloedgraven, C. van der Bent, J.W. Drijfhout, J. Verheijen, P. Quax, M. Karperien, S. Papapoulos, and C. Lowik Urokinase-receptor/integrin complexes are functionally involved in adhesion and progression of human breast cancer in vivo Am J Pathol 159 2001 971 982
89. K. Aigner, B. Dampier, L. Descovich, M. Mikula, A. Sultan, M. Schreiber, W. Mikulits, T. Brabletz, D. Strand, P. Obrist, W. Sommergruber, N. Schweifer, A. Wernitznig, H. Beug, R. Foisner, and A. Eger The transcription factor ZEB1 (deltaEF1) promotes tumour cell dedifferentiation by repressing master regulators of epithelial polarity Oncogene 26 2007 6979 6988
90. M.H. Yang, D.S. Hsu, H.W. Wang, H.J. Wang, H.Y. Lan, W.H. Yang, C.H. Huang, S.Y. Kao, C.H. Tzeng, S.K. Tai, S.Y. Chang, O.K. Lee, and K.J. Wu Bmi1 is essential in Twist1-induced epithelial-mesenchymal transition Nat Cell Biol 12 2010 982 992
91. A. Cano, M.A. Perez-Moreno, I. Rodrigo, A. Locascio, M.J. Blanco, M.G. del Barrio, F. Portillo, and M.A. Nieto The transcription factor snail controls epithelial-mesenchymal transitions by repressing E-cadherin expression Nat Cell Biol 2 2000 76 83
92. G. Moreno-Bueno, E. Cubillo, D. Sarrio, H. Peinado, S.M. Rodriguez-Pinilla, S. Villa, V. Bolos, M. Jorda, A. Fabra, F. Portillo, J. Palacios, and A. Cano Genetic profiling of epithelial cells expressing E-cadherin repressors reveals a distinct role for Snail, Slug, and E47 factors in epithelial-mesenchymal transition Cancer Res 66 2006 9543 9556
93. V. Bolos, H. Peinado, M.A. Perez-Moreno, M.F. Fraga, M. Esteller, and A. Cano The transcription factor Slug represses E-cadherin expression and induces epithelial to mesenchymal transitions: a comparison with Snail and E47 repressors J Cell Sci 116 2003 499 511
94. T. Lin, A. Ponn, X. Hu, B.K. Law, and J. Lu Requirement of the histone demethylase LSD1 in Snai1-mediated transcriptional repression during epithelial-mesenchymal transition Oncogene 29 2010 4896 4904
95. C. Dong, Y. Wu, J. Yao, Y. Wang, Y. Yu, P.G. Rychahou, B.M. Evers, and B.P. Zhou G9a interacts with Snail and is critical for Snail-mediated E-cadherin repression in human breast cancer J Clin Invest 122 2012 1469 1486
96. Y. Mizuguchi, S. Specht, J.G. Lunz 3rd, K. Isse, N. Corbitt, T. Takizawa, and A.J. Demetris Cooperation of p300 and PCAF in the control of microRNA 200c/141 transcription and epithelial characteristics PLoS One 7 2012 e32449
97. C. Yokomizo, K. Yamaguchi, Y. Itoh, T. Nishimura, A. Umemura, M. Minami, K. Yasui, H. Mitsuyoshi, H. Fujii, N. Tochiki, T. Nakajima, T. Okanoue, and T. Yoshikawa High expression of p300 in HCC predicts shortened overall survival in association with enhanced epithelial mesenchymal transition of HCC cells Cancer Lett 310 2011 140 147
98. D. Iliopoulos, M. Lindahl-Allen, C. Polytarchou, H.A. Hirsch, P.N. Tsichlis, and K. Struhl Loss of miR-200 inhibition of Suz12 leads to polycomb-mediated repression required for the formation and maintenance of cancer stem cells Mol Cell 39 2010 761 772
99. G. Chinnadurai CtBP, an unconventional transcriptional corepressor in development and oncogenesis Mol Cell 9 2002 213 224
100. L.J. Di, A.G. Fernandez, A. De Siervi, D.L. Longo, and K. Gardner Transcriptional regulation of BRCA1 expression by a metabolic switch Nat Struct Mol Biol 17 2010 1406 1413
101. L.J. Di, J.S. Byun, M.M. Wong, C. Wakano, T. Taylor, S. Bilke, S. Baek, K. Hunter, H. Yang, M. Lee, C. Zvosec, G. Khramtsova, F. Cheng, C.M. Perou, C. Ryan Miller, R. Raab, O.I. Olopade, and K. Gardner Genome-wide profiles of CtBP link metabolism with genome stability and epithelial reprogramming in breast cancer Nat Commun 4 2013 1449
102. J.I. Yook, X.Y. Li, I. Ota, C. Hu, H.S. Kim, N.H. Kim, S.Y. Cha, J.K. Ryu, Y.J. Choi, J. Kim, E.R. Fearon, and S.J. Weiss A Wnt-Axin2-GSK3beta cascade regulates Snail1 activity in breast cancer cells Nat Cell Biol 8 2006 1398 1406
103. S. Sell On the stem cell origin of cancer Am J Pathol 176 2010 2584-2494
104. S.A. Mani, W. Guo, M.J. Liao, E.N. Eaton, A. Ayyanan, A.Y. Zhou, M. Brooks, F. Reinhard, C.C. Zhang, M. Shipitsin, L.L. Campbell, K. Polyak, C. Brisken, J. Yang, and R.A. Weinberg The epithelial-mesenchymal transition generates cells with properties of stem cells Cell 133 2008 704 715
105. F. Clavel-Chapelon Differential effects of reproductive factors on the risk of pre- and postmenopausal breast cancer: results from a large cohort of French women Br J Cancer 86 2002 723 727
106. A.I. Phipps, R.T. Chlebowski, R. Prentice, A. McTiernan, J. Wactawski-Wende, L.H. Kuller, L.L. Adams-Campbell, D. Lane, M.L. Stefanick, M. Vitolins, G.C. Kabat, T.E. Rohan, and C.I. Li Reproductive history and oral contraceptive use in relation to risk of triple-negative breast cancer J Natl Cancer Inst 103 2011 470 477
107. T.A. Sellers, L.H. Kushi, J.D. Potter, S.A. Kaye, C.L. Nelson, P.G. McGovern, and A.R. Folsom Effect of family history, body-fat distribution, and reproductive factors on the risk of postmenopausal breast cancer N Engl J Med 326 1992 1323 1329
108. A.L. Johansson, T.M. Andersson, C.C. Hsieh, S. Cnattingius, and M. Lambe Increased mortality in women with breast cancer detected during pregnancy and different periods postpartum Cancer Epidemiol Biomarkers Prev 20 2011 1865 1872
109. R.C. Millikan, B. Newman, C.K. Tse, P.G. Moorman, K. Conway, L.G. Dressler, L.V. Smith, M.H. Labbok, J. Geradts, J.T. Bensen, S. Jackson, S. Nyante, C. Livasy, L. Carey, H.S. Earp, and C.M. Perou Epidemiology of basal-like breast cancer Breast Cancer Res Treat 109 2008 123 139
110. S.M. McDaniel, K.K. Rumer, S.L. Biroc, R.P. Metz, M. Singh, W. Porter, and P. Schedin Remodeling of the mammary microenvironment after lactation promotes breast tumor cell metastasis Am J Pathol 168 2006 608 620
111. J. O'Brien, T. Lyons, J. Monks, M.S. Lucia, R.S. Wilson, L. Hines, Y.G. Man, V. Borges, and P. Schedin Alternatively activated macrophages and collagen remodeling characterize the postpartum involuting mammary gland across species Am J Pathol 176 2010 1241 1255
112. T.R. Lyons, J. O'Brien, V.F. Borges, M.W. Conklin, P.J. Keely, K.W. Eliceiri, A. Marusyk, A.C. Tan, and P. Schedin Postpartum mammary gland involution drives progression of ductal carcinoma in situ through collagen and COX-2 Nat Med 17 2011 1109 1115
113. S. Kobayashi, H. Sugiura, Y. Ando, N. Shiraki, T. Yanagi, H. Yamashita, and T. Toyama Reproductive history and breast cancer risk Breast Cancer 19 2012 302 308
114. F. Sotgia, M.C. Casimiro, G. Bonuccelli, M. Liu, D. Whitaker-Menezes, O. Er, K.M. Daumer, I. Mercier, A.K. Witkiewicz, C. Minetti, F. Capozza, M. Gormley, A.A. Quong, H. Rui, P.G. Frank, J.N. Milliman, E.S. Knudsen, J. Zhou, C. Wang, R.G. Pestell, and M.P. Lisanti Loss of caveolin-3 induces a lactogenic microenvironment that is protective against mammary tumor formation Am J Pathol 174 2009 613 629
115. S.B. Baylin, and P.A. Jones A decade of exploring the cancer epigenome: biological and translational implications Nat Rev Cancer 11 2011 726 734
116. O.G. McDonald, H. Wu, W. Timp, A. Doi, and A.P. Feinberg Genome-scale epigenetic reprogramming during epithelial-to-mesenchymal transition Nat Struct Mol Biol 18 2011 867 874
117. B. Wen, H. Wu, Y. Shinkai, R.A. Irizarry, and A.P. Feinberg Large histone H3 lysine 9 dimethylated chromatin blocks distinguish differentiated from embryonic stem cells Nat Genet 41 2009 246 250
118. A. Chalkiadaki, and L. Guarente Sirtuins mediate mammalian metabolic responses to nutrient availability Nat Rev Endocrinol 8 2012 287 296
119. W. Xu, H. Yang, Y. Liu, Y. Yang, P. Wang, S.H. Kim, S. Ito, C. Yang, M.T. Xiao, L.X. Liu, W.Q. Jiang, J. Liu, J.Y. Zhang, B. Wang, S. Frye, Y. Zhang, Y.H. Xu, Q.Y. Lei, K.L. Guan, S.M. Zhao, and Y. Xiong Oncometabolite 2-hydroxyglutarate is a competitive inhibitor of alpha-ketoglutarate-dependent dioxygenases Cancer Cell 19 2011 17 30